These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2989413)

  • 21. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.
    Joncas JH; Wills A; Reece E; Fox Z
    Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis.
    Gregory CD; Dive C; Henderson S; Smith CA; Williams GT; Gordon J; Rickinson AB
    Nature; 1991 Feb; 349(6310):612-4. PubMed ID: 1705663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus with the latent infection nuclear antigen 3B completely deleted is still competent for B-cell growth transformation in vitro.
    Chen A; Divisconte M; Jiang X; Quink C; Wang F
    J Virol; 2005 Apr; 79(7):4506-9. PubMed ID: 15767450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of Epstein-Barr virus nuclear antigen(s) in different cell lines by radioimmunoelectrophoresis.
    Sculley TB; Spelsberg TC; Pearson GR
    Intervirology; 1984; 22(4):191-200. PubMed ID: 6096291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of a second Epstein-Barr virus-determined nuclear antigen in mouse cells after gene transfer with a cloned fragment of the viral genome.
    Rymo L; Klein G; Ricksten A
    Proc Natl Acad Sci U S A; 1985 May; 82(10):3435-9. PubMed ID: 2987926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3).
    Burrows SR; Sculley TB; Misko IS; Schmidt C; Moss DJ
    J Exp Med; 1990 Jan; 171(1):345-9. PubMed ID: 1688611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses.
    Murray RJ; Kurilla MG; Griffin HM; Brooks JM; Mackett M; Arrand JR; Rowe M; Burrows SR; Moss DJ; Kieff E
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):2906-10. PubMed ID: 2158098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B cell activation by the nontransforming P3HR-1 substrain of the Epstein-Barr virus (EBV).
    Hu CP; Aman P; Masucci MG; Klein E; Klein G
    Eur J Immunol; 1986 Jul; 16(7):841-5. PubMed ID: 3013647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures.
    Cuomo L; Trivedi P; Wang F; Winberg G; Klein G; Masucci MG
    Eur J Immunol; 1990 Oct; 20(10):2293-9. PubMed ID: 2173662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotype, frequency, and EBV responsiveness of human marrow B and pre-B cells.
    Hibi T; Chan MA; Petsche D; Dosch HM
    J Immunol; 1986 May; 136(9):3211-8. PubMed ID: 3007613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of B lymphocytes by Epstein-Barr virus/CR2 receptor interaction.
    Masucci MG; Szigeti R; Ernberg I; Hu CP; Torsteinsdottir S; Frade R; Klein E
    Eur J Immunol; 1987 Jun; 17(6):815-20. PubMed ID: 3036539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneity of EBV-transformable human B lymphocyte populations.
    Chan MA; Stein LD; Dosch HM; Sigal NH
    J Immunol; 1986 Jan; 136(1):106-12. PubMed ID: 2999241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of Epstein-Barr virus activation of human B lymphocytes.
    Bird AG; Britton S; Ernberg I; Nilsson K
    J Exp Med; 1981 Sep; 154(3):832-9. PubMed ID: 6268732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr virus infection of rat lymphocytes expressing human CD21 results in restricted latent viral gene expression and not in immunoblastic transformation.
    Yang L; Ikeda H; Lai Y; Yoshiki T; Takada K
    J Med Virol; 2003 May; 70(1):126-30. PubMed ID: 12629653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines.
    Dillner J; Kallin B; Alexander H; Ernberg I; Uno M; Ono Y; Klein G; Lerner RA
    Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6641-5. PubMed ID: 3018741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA-binding studies of the Epstein-Barr virus nuclear antigen 2 (EBNA-2): evidence for complex formation by latent membrane protein gene promoter-binding proteins in EBNA-2-positive cell lines.
    Sauder C; Haiss P; Grässer FA; Zimber-Strobl U; Mueller-Lantzsch N
    J Gen Virol; 1994 Nov; 75 ( Pt 11)():3067-79. PubMed ID: 7964616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimation of B-cells transformed by Epstein-Barr virus in patients with congenital agammaglobulinemia.
    Tsuchiya S; Nakae S; Konno T; Tada K; Ono Y
    Tohoku J Exp Med; 1981 Dec; 135(4):379-85. PubMed ID: 6278674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Establishment and characterization of EBNA-negative, EBV-genome DNA-positive B cell lines].
    Nakano M; Toyama K; Niizuma M; Hayata Y
    Nihon Ketsueki Gakkai Zasshi; 1988 May; 51(3):596-605. PubMed ID: 2844050
    [No Abstract]   [Full Text] [Related]  

  • 39. Tonsillar CD56brightNKG2A+ NK cells restrict primary Epstein-Barr virus infection in B cells via IFN-γ.
    Jud A; Kotur M; Berger C; Gysin C; Nadal D; Lünemann A
    Oncotarget; 2017 Jan; 8(4):6130-6141. PubMed ID: 28008151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies on transformation of human lymphocytes by Epstein-Barr virus (author's transl)].
    Takada K
    Hokkaido Igaku Zasshi; 1980 Sep; 55(5):447-70. PubMed ID: 6263773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.